Effective VA-ECMO Intervention for Severe Cardiotoxicity Induced by Neoadjuvant Paclitaxel and Cisplatin in Laryngeal Cancer: A Case Study - Top-Institutions - MDSpire

Effective VA-ECMO Intervention for Severe Cardiotoxicity Induced by Neoadjuvant Paclitaxel and Cisplatin in Laryngeal Cancer: A Case Study

  • By

  • Yan Qian

  • Youjun Pan

  • Zhiru Che

  • Ke Fang

  • Yingya Cao

  • Xiaogan Jiang

  • Weihua Lu

  • Qiancheng Xu

  • December 15, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cardio-Oncology
    • Medical Oncology
    • Mechanical Circulatory Support
  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Oncology
    • Advanced Heart Failure and ECMO
  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Oncology
    • Mechanical Circulatory Support
  • #4

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Cardio-Oncology
    • Medical Oncology
    • Critical Care and ECMO
  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Oncology
    • ECMO and Mechanical Circulatory Support

Original Source(s)

Related Content